Table 1.

Free-fraction-corrected FCWAY Volume of distribution in healthy controls and patients with TLE

Region	Controls (n=15)			Patients (n=11)#			p
I. frontal	69.0	±	23.7	62.7	±	14.0	0.45
C. frontal	68.3	±	22.0	63.0	±	15.1	0.50
I. insular	85.2	±	39.7	64.1	±	16.9	0.08
C. insular	87.1	±	38.3	68.6	±	15.7	0.11
I. hippocampus	116.2	±	43.1	81.3	±	23.3	0.02*
C. hippocampus	116.5	±	43.7	90.5	±	25.6	0.07
I. amygdala	70.8	±	26.4	58.8	±	24.9	0.25
C. amygdala	73.7	±	26.9	69.0	±	23.9	0.64
I. parahippocampus	125.8	±	56.2	86.7	±	17.2	0.02*
C. parahippocampus	125.6	±	58.0	99.6	±	21.5	0.13
I. superior temporal	81.1	±	35.8	71.7	±	19.3	0.40
C. superior temporal	81.4	±	30.6	80.2	±	14.3	0.89
I. middle temporal	88.5	±	36.8	77.3	±	22.4	0.38
C. middle temporal	87.8	±	31.1	88.1	±	17.3	0.98
I. inferior temporal	95.5	±	36.7	81.0	±	24.7	0.27
C. inferior temporal	98.0	±	32.7	94.8	±	25.1	0.79
I. fusiform	115.1	±	47.1	82.2	±	22.0	0.03*
C. fusiform	112.9	±	43.0	101.3	±	22.2	0.38

^#patient 12 was excluded

I.=ipsilateral to seizure focus (arbitrarily right for controls).

C.=contralateral to seizure focus.

^*P<0.05, unpaired t-test, patients vs. controls.